Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Amortizatization of Intangibles: 2020-2024

Historic Amortizatization of Intangibles for Avidity Biosciences (RNA) over the last 5 years, with Dec 2024 value amounting to $21.4 million.

  • Avidity Biosciences' Amortizatization of Intangibles fell 64.87% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 million, marking a year-over-year increase of 3.91%. This contributed to the annual value of $21.4 million for FY2024, which is 90.23% up from last year.
  • According to the latest figures from FY2024, Avidity Biosciences' Amortizatization of Intangibles is $21.4 million, which was up 90.23% from $11.3 million recorded in FY2023.
  • In the past 5 years, Avidity Biosciences' Amortizatization of Intangibles registered a high of $21.4 million during FY2024, and its lowest value of -$9,000 during FY2020.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $11.3 million (2023), whereas its average is $11.8 million.
  • Data for Avidity Biosciences' Amortizatization of Intangibles shows a peak YoY skyrocketed of 7,822.22% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Avidity Biosciences' Amortizatization of Intangibles stood at -$9,000 in 2020, then surged by 7,822.22% to $695,000 in 2021, then surged by 295.54% to $2.7 million in 2022, then spiked by 310.11% to $11.3 million in 2023, then surged by 90.23% to $21.4 million in 2024.